Predictive value of 18F-fluorodeoxyglucose accumulation in visceral fat activity to detect colorectal cancer metastases (prospective observational cohort study)
- PMID: 37360938
- PMCID: PMC10285332
- DOI: 10.12688/f1000research.122814.1
Predictive value of 18F-fluorodeoxyglucose accumulation in visceral fat activity to detect colorectal cancer metastases (prospective observational cohort study)
Abstract
Background: To evaluate functional visceral adipose tissue (VAT) activity assessed by 18F-fluorodeoxyglucose ( 18F-FDG) positron emission tomography/computed tomography (PET/CT) as a predictive factor of metastases in colorectal cancer (CRC) patients. Methods: We reviewed study protocols and PET/CT data of 534 CRC patients; 474 patients were subsequently excluded for various reasons. The remaining 60 patients with histologically confirmed adenocarcinoma were then prospectively assessed and were exposed to 18F-FDG PET/CT after a surgical treatment and chemoradiotherapy. Age, histology, stage, and tumor grade data were recorded. Functional VAT activity was verified with maximum standardized uptake value (SUV max) using 18F-FDG PET/CT and tested as a predictive factor of later metastases in eight subdomains of abdominal regions (RE - epigastric region, RLH - left hypochondriac region, RRL - right lumbar region, RU - umbilical region, RLL - left lumbar region, RRI - right inguinal region, RP - hypogastric (pubic) region, RLI - left inguinal region) and pelvic cavity (P) in the adjusted regression models. In addition, we studied the best areas under the curve (AUC) for SUV max with the corresponding sensitivity (Se) and specificity (Sp). Results: In both adjusted for age regression models and receiver operating characteristic (ROC) curve analysis, 18F-FDG accumulation in RLH (cut-off SUV max 0.74; Se 75%; Sp 61%; AUC 0.668; p=0.049), RU (cut-off SUV max 0.78; Se 69%; Sp 61%; AUC 0.679; p=0.035), RRL (cut-off SUV max 1.05; Se 69%; Sp 77%; AUC 0.682; p=0.032) and RRI (cut-off SUV max 0.85; Se 63%; Sp 61%; AUC 0.672; p=0.043) could predict later metastases in CRC patients, as opposed to age, sex, primary tumor location, tumor grade and histology. Conclusions: Functional VAT activity was importantly related to later metastases in CRC patients and can be used as their predictive factor.
Keywords: 18F-FDG; Colorectal cancer; PET/CT; Predictive value.
Copyright: © 2022 Suleimanov A et al.
Conflict of interest statement
No competing interests were disclosed.
Figures




Similar articles
-
Predictive Role of Functional Visceral Fat Activity Assessed by Preoperative F-18 FDG PET/CT for Regional Lymph Node or Distant Metastasis in Patients with Colorectal Cancer.PLoS One. 2016 Feb 10;11(2):e0148776. doi: 10.1371/journal.pone.0148776. eCollection 2016. PLoS One. 2016. PMID: 26862754 Free PMC article.
-
[The correlation between metabolic parameters in (18)F-FDG PET-CT and solid and micropapillary histological subtypes in lung adenocarcinoma].Zhonghua Zhong Liu Za Zhi. 2022 Jun 23;44(6):555-561. doi: 10.3760/cma.j.cn112152-20200804-00710. Zhonghua Zhong Liu Za Zhi. 2022. PMID: 35754230 Chinese.
-
Change of maximum standardized uptake value slope in dynamic triphasic [18F]-fluorodeoxyglucose positron emission tomography/computed tomography distinguishes malignancy from postradiation inflammation in head-and-neck squamous cell carcinoma: a prospective trial.Int J Radiat Oncol Biol Phys. 2015 Mar 1;91(3):472-9. doi: 10.1016/j.ijrobp.2014.11.002. Epub 2015 Jan 30. Int J Radiat Oncol Biol Phys. 2015. PMID: 25680593 Free PMC article.
-
Performance Evaluation of a Semi-automated Method for [18F]FDG Uptake in Abdominal Visceral Adipose Tissue.Mol Imaging Biol. 2019 Feb;21(1):159-167. doi: 10.1007/s11307-018-1211-1. Mol Imaging Biol. 2019. PMID: 29789994
-
Role of PET/Computed Tomography in Gastric and Colorectal Malignancies.PET Clin. 2024 Apr;19(2):177-186. doi: 10.1016/j.cpet.2023.12.004. Epub 2024 Jan 9. PET Clin. 2024. PMID: 38199915 Review.
Cited by
-
Nano-Radiopharmaceuticals in Colon Cancer: Current Applications, Challenges, and Future Directions.Pharmaceuticals (Basel). 2025 Feb 14;18(2):257. doi: 10.3390/ph18020257. Pharmaceuticals (Basel). 2025. PMID: 40006069 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical